BodEvolve Bariatric & Cosmetic Surgery

What BodEvolve Bariatric & Cosmetic Surgery does

BodEvolve Bariatric & Cosmetic Surgery is a privately held medical practice headquartered in Richardson, Texas, operating within the Dallas-Fort Worth metroplex from four locations (Arlington, Richardson, Dallas, and Texarkana). The practice delivers a full continuum of bariatric surgical procedures—including Gastric Sleeve, Gastric Bypass, Duodenal Switch, SADI-S, and Revision Weight Loss Surgery—alongside a non-surgical Medical Weight Management program and an integrated post-bariatric cosmetic surgery service line (360 Liposuction, Tummy Tuck, Back Lift, Fat Transfer Brazilian Butt Lift, and Breast Lift). It serves individual patients with severe obesity (typically BMI 35+) seeking surgical intervention and post-weight-loss aesthetic restoration.

The clinical operation is built on minimally invasive laparoscopic surgical techniques and is led by Dr. Clayton Frenzel (triple board-certified, dual fellowship-trained, 15+ years of experience, FASMBS/FACS credentials) and Dr. Brian Holt (bariatric surgeon, current AACS Cosmetic Fellow). The practice reports having performed 14,000+ bariatric procedures cumulatively with documented outcomes of 70-90% excess weight loss, 85% diabetes resolution, and 90% sleep apnea improvement. It holds ASMBS Center of Excellence accreditation and operates multiple triple board-certified surgeon credentials as primary credibility anchors.

The revenue model combines one-time procedure-based revenue from bariatric and cosmetic surgeries with a recurring subscription stream from Medical Weight Management. Patient acquisition is sales-led and consultation-driven, executed through website booking, phone inquiries, paid traditional media (radio, TV, streaming), YouTube patient testimonials, Google Business Profile/SEO, social media, and patient referrals. The practice accepts major insurance with benefit verification and offers third-party financing. A sub-brand, BodEvolve Cosmetic, hosts the post-bariatric aesthetic offering on a dedicated website. The business is independently owned with no disclosed venture capital, private equity backing, or parent company.

Name

BodEvolve Bariatric & Cosmetic Surgery

Legal name

BodEvolve Bariatric & Cosmetic Surgery

Website

https://mycompletetransformation.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

BodEvolve is a private Dallas-Fort Worth medical practice performing bariatric surgery (Gastric Sleeve, Bypass, Duodenal Switch, SADI-S), revision procedures, medical weight management, and post-bariatric cosmetic surgery across four Texas locations, serving patients with severe obesity.

Ownership category

akta.pro rank

Product category

Bariatric Surgery Services

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

Keywords

• Bariatric surgery services
• Weight loss surgery
• Cosmetic surgery
• Medical weight management
• Post-bariatric body contouring

Headquarters

HQ city

Fort Richardson

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Bariatric Surgical Procedures: One-time surgical procedures including Gastric Sleeve, Gastric Bypass, Duodenal Switch, and SADI-S. Revenue generated per procedure with pricing varying by complexity and insurance coverage.
2. Cosmetic Surgery Procedures: Post-bariatric cosmetic procedures including body contouring, tummy tucks, liposuction, and breast lifts. One-time surgical revenue.
3. Medical Weight Management: Non-surgical weight management program including medications, nutrition counseling, and lifestyle coaching. Ongoing care model.
4. Revision Weight Loss Surgery: Corrective procedures for patients with complications or inadequate results from previous bariatric surgery.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

BodEvolve Bariatric & Cosmetic Surgery is a private medical practice that performs bariatric surgical procedures including Gastric Sleeve, Gastric Bypass, Duodenal Switch, and SADI-S, as well as Revision Weight Loss Surgery for prior bariatric patients. The practice also provides a non-surgical Medical Weight Management program and post-bariatric cosmetic procedures (body contouring, tummy tucks, liposuction, breast lifts) through its BodEvolve Cosmetic sub-brand, with comprehensive pre- and post-operative support including nutrition, psychology, and lifelong follow-up.

Product overview

BodEvolve Bariatric & Cosmetic Surgery operates as a comprehensive medical practice offering a full spectrum of bariatric surgery procedures and supporting services. The core offering centers on surgical weight loss procedures—Gastric Sleeve, Gastric Bypass, Duodenal Switch, SADI-S, and Revision Weight Loss Surgery—supported by a Medical Weight Management program for non-surgical approaches. An integrated Cosmetic Plastic Surgery module provides post-bariatric body contouring procedures including liposuction, tummy tuck, back lift, fat transfer Brazilian Butt Lift, and breast lift. The practice also provides ancillary services including nutrition support, psychology services, insurance coordination, financing options, and lifelong patient support, all delivered at multiple DFW locations (Arlington, Richardson, Dallas, Texarkana).

Differentiator

Problem solved

Functional benefit

Brands

• BodEvolve Cosmetic: Separate website (bodevolvecosmetic.com) offering post-bariatric cosmetic procedures including 360 Liposuction, Tummy Tuck, Back Lift, Fat Transfer Brazilian Butt Lift, and Breast Lift

Products and services

• Gastric Sleeve (Laparoscopic Sleeve Gastrectomy) Laparoscopic procedure that removes approximately 75% of the stomach to create a banana-shaped sleeve, reducing hunger hormones and producing 60–70% excess weight loss without intestinal rerouting. Intended for patients with severe obesity seeking surgical weight loss.
• Gastric Bypass (Roux-en-Y Gastric Bypass) Procedure that creates a small stomach pouch and bypasses part of the small intestine, achieving 70–80% excess weight loss with strong diabetes resolution and long-term results. Intended for patients with severe obesity, particularly with metabolic comorbidities.
• Duodenal Switch (Biliopancreatic Diversion) Combination of sleeve gastrectomy and intestinal bypass designed for severe obesity and diabetes, achieving 80–90% excess weight loss and the highest diabetes resolution rate while maintaining nutritional balance. Intended for patients with severe obesity and significant metabolic disease.
• SADI-S (Single Anastomosis Duodeno-Ileostomy) Simplified variant of the duodenal switch that achieves 75–85% excess weight loss and strong diabetes control with lower complication rates. Intended for patients with severe obesity seeking durable metabolic outcomes.
• Revision Weight Loss Surgery Corrective bariatric procedures to address complications or inadequate weight loss from a previous weight loss surgery, aimed at improving outcomes and quality of life. Intended for patients who have had prior bariatric surgery with poor results or complications.
• Medical Weight Management Non-surgical weight management program that combines prescription medications, nutritional counseling, and lifestyle coaching to support ongoing weight loss. Intended for patients who want a non-surgical approach or who are not candidates for bariatric surgery.
• Cosmetic Plastic Surgery Post-bariatric cosmetic procedures including 360 Liposuction, Tummy Tuck, Back Lift, Fat Transfer Brazilian Butt Lift, and Breast Lift to remove excess skin and restore body confidence after major weight loss. Intended for patients who have completed significant weight loss and need body contouring.

Quantifiable outcome

• 70-90% excess weight loss
• +5 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Ro: Direct-to-patient telehealth platform with a weight loss program built around GLP-1 prescribing. Overlaps with BodEvolve's medical weight management line and represents the digitally native alternative that may divert early-stage obesity patients from surgical consults.
• LifeMD: Telehealth company offering clinician-led weight management programs including GLP-1 medication pathways. Competes with BodEvolve's non-surgical Medical Weight Management offering and signals the broader shift toward virtual obesity care.
• Hims & Hers Health: Direct-to-consumer telehealth platform that has rapidly expanded into medical weight management via GLP-1 prescriptions. Represents a non-surgical, technology-enabled alternative pathway that competes for the same obesity-treatment patient funnel at the top of the funnel.

Direct peers

• Austin-Weston Center for Cosmetic Surgery: Multi-surgeon cosmetic surgery center offering body contouring, tummy tucks, and post-weight-loss procedures. Direct peer for BodEvolve's BodEvolve Cosmetic sub-brand in the post-bariatric aesthetic segment.
• NYC Bariatric Group: Multi-surgeon bariatric and revision surgery practice with multiple locations. Direct competitor in the same product category (Gastric Sleeve, Bypass, revisions, medical weight management) and similar consultation-led GTM targeting self-pay and insured patients.
• Texas Bariatric Specialists: Texas-based bariatric surgery practice offering gastric sleeve, bypass, revisions, and medical weight management. Closest geographic and product-line peer; competes for the same DFW-adjacent patient pool and uses a similar outcomes-driven marketing approach.

Broad incumbents

• Mayo Clinic: Top-tier academic health system with a comprehensive bariatric and metabolic surgery program. Competes for medical-travel and complex-revision patients seeking maximum institutional credibility, and sets the upper bar for outcomes reporting.
• Cleveland Clinic Bariatric & Metabolic Institute: Established academic medical center with a high-volume, multi-surgeon bariatric program including research and complex revisions. A broad incumbent competitor that attracts patients seeking a hospital-system setting over an independent practice.

Others

• Novo Nordisk: Manufacturer of semaglutide (Ozempic/Wegovy), the leading GLP-1 obesity medication. Not a direct service competitor, but its products are reshaping demand for bariatric surgery and influencing payer and patient behavior toward medication-first pathways.
• Eli Lilly: Manufacturer of tirzepatide (Mounjaro/Zepbound), a highly effective GLP-1/GIP obesity therapy. An enabling/adversarial ecosystem player whose commercial success in obesity directly affects the addressable surgical population over time.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/embed/9LtNM2rnI_4
• Facebookfacebook.com/BodEvolveBariatricSurgery
• LinkedInlinkedin.com/company/bodevolve-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BodEvolve Bariatric & Cosmetic Surgery